Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Svea Vaccin AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 131,384 More Arrow 200,780 Less Arrow 169,152
Financial expenses 111 Less Arrow 56 Less Arrow 0
Earnings before taxes -24,906 More Arrow 16,556 More Arrow 18,750
EBITDA -23,873 More Arrow 16,789 More Arrow 18,033
Total assets 22,857 More Arrow 46,228 Less Arrow 37,262
Current assets 16,199 More Arrow 42,835 Less Arrow 33,969
Current liabilities 18,458 More Arrow 26,923 Less Arrow 20,763
Equity capital 4,399 More Arrow 17,545 Less Arrow 15,509
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 94 Less Arrow 91 Less Arrow 65

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 19.2% More Arrow 38.0% More Arrow 41.6%
Turnover per employee 1,398 More Arrow 2,206 More Arrow 2,602
Profit as a percentage of turnover -19.0% More Arrow 8.2% More Arrow 11.1%
Return on assets (ROA) -108.5% More Arrow 35.9% More Arrow 50.3%
Current ratio 87.8% More Arrow 159.1% More Arrow 163.6%
Return on equity (ROE) -566.2% More Arrow 94.4% More Arrow 120.9%
Change turnover -69,396 More Arrow 31,628 Less Arrow -64,716
Change turnover % -35% More Arrow 19% Less Arrow -28%
Chg. No. of employees 3 More Arrow 26 Less Arrow -15
Chg. No. of employees % 3% More Arrow 40% Less Arrow -19%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.